Navigation Links
Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
Date:6/11/2008

SEATTLE and PARIS, June 12 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation (Nasdaq: TGEN) announced today that positive results of a Phase 1/2 clinical study demonstrate that tgAAC94, its investigational agent designed to inhibit activity of tumor necrosis factor-alpha (TNF-alpha), a key mediator of inflammation, is well tolerated and may improve disease symptoms in inflammatory arthritis patients refractory to other therapies, including systemic TNF antagonists. Full results of the study were presented here today during an oral presentation at the Annual European Congress of Rheumatology (EULAR).

The Phase 1/2 study evaluated multiple doses of tgAAC94 administered directly to affected joints with or without concurrent systemic TNF antagonist therapies. The study achieved its primary endpoint of safety and tolerability.

"We are encouraged by the patient-reported symptom improvement -- early signs of efficacy that indicate further study is warranted," said Philip Mease, M.D., Chief, Rheumatology Clinical Research Division of Swedish Hospital Medical Center and Head of Seattle Rheumatology Associates, who presented the data.

Study Details

127 patients with inflammatory arthritis received a single intra-articular injection of either tgAAC94 or placebo, followed by a second injection 12-30 weeks later depending on when the injected joint met criteria for re-injection. tgAAC94 was well tolerated at all dose levels. Two SAEs of focused interest were reported -- a culture-negative septic arthritis considered probably related to study drug and a fatal disseminated histoplasmosis and retroperitoneal hemorrhage considered not related to study agent. Administration site reactions were observed in 12% of subjects.
'/>"/>

SOURCE Targeted Genetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkins Lymphoma
2. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
3. Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
4. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
5. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
6. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
7. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
8. Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
9. Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma
10. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
11. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015  Xcelience, a contract development and ... made a structured cash investment in Powdersize, a ... milling, micronization and powder size classification within the ... business while simultaneously adding a complete set of ... capabilities. "As we continue to ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 ... announced it has signed a definitive agreement ... provider of non-invasive ventilation and sleep-disordered breathing ... strong clinical, innovation and market reputation in China, combined with ResMed,s global leadership ... of people in China ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... LOS ANGELES, May 16, 2012  NeuroSigma, Inc., a ... its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a ... the fabrication of Thin-Film Nitinol (TFN) from TiNi ... "Three Dimensional Thin Film Devices and Methods of ...
... 2012  Rigel Pharmaceuticals, Inc., (Nasdaq: RIGL ) ... innovative, comprehensive treatment alternatives for patients with asthma. One ... be entering a Phase 2 clinical study later this ... R256, an inhaled IL13 signaling/JAK inhibitor, is potentially useful ...
Cached Medicine Technology:NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 2NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 2Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 4
(Date:8/1/2015)... Bronx, NY (PRWEB) , ... August 01, 2015 , ... ... Torah scroll currently housed at their Bronx campus. The goal is to bring this ... once again be used in Jewish rituals and religious services. , Scroll No. ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released a ... to have been behind the attack on Anthem Inc. which resulted in one of ... watering hole attacks and spear phishing campaigns. , For Joe Caruso, founder ...
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine ... mile trek of the Appalachian Trail by stepping off Springer Mountain and heading ... , On July 26th Phil reached Connecticut and was greeted by friends and family. ...
(Date:7/31/2015)... ... ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened a regional ... 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and Latin America(1) ... and Allied Health Personnel Development, Unit of Human Resources for Health, Department of Health ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... ... Wilson, Williams and West in regards to losses of IQ and Emotional Intelligence. Take EI ... ... of viewers Joe Wilson shouts "you lie, to the president, Serena Williams calls out line ...
... ... award for second year, based on superior academic performance and record of community service. Born ... in Southern California. , ... Angeles, CA (PRWEB) September 28, 2009 -- The David Geffen School of Medicine at UCLA ...
... , ... HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group are pleased to ... to serve as a resource for human capital thought leadership in the healthcare workplace ... ...
... ... Aging Services Access Point (ASAP) with main offices in Brockton has launched a Supportive ... live longer in the community and preventing premature institutionalization. , ... Plymouth County and Avon, Easton and Stoughton, ...
... more likely to die than patients with higher incomes. That ... to be published in the December 1, 2009 issue of ... Society. The study,s findings indicate that poor prostate cancer patients ... the previous studies on socioeconomic status (SES) and prostate cancer ...
... 2009) - Antibiotic resistance has been a significant problem for ... despite the need for new treatment options, there have been ... 40 years. Now a promising discovery by McMaster University ... interventions for resistant infections. Eric Brown, a professor and ...
Cached Medicine News:Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 2Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 3Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 4Health News:Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 2Health News:Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 3Health News:Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 4Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 2Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 3Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 4Health News:Old Colony Elder Services Launches Supportive Housing Program in Plymouth 2Health News:Old Colony Elder Services Launches Supportive Housing Program in Plymouth 3Health News:Swiss study finds income affects prostate cancer patients' survival 2Health News:McMaster researchers discover a new antibacterial lead 2
... Contrast Sensitivity is Recognized as a ... Loss Caused by Early Eye Disease. ... in x 7 in (12.7cm x ... on a Refractor,Distance Test F.A.C.T. ...
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Medicine Products: